In human AML cell lines we compared dose-dependent responses to AZA and DAC on cell viability, protein synthesis, DNMT1 depletion, hypomethylation of DNA, induction of DNA damage, cell cycle, induction of apoptosis, and gene expression. The gene discussed is DNMT1; the disease is acute myeloid leukemia.